Position in GRFS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$117,655
-$109,383 QoQ
Shares Held
16,618
-41.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 164 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $186,163,406 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
68,190 | $81,789,138 | |
| 2 | JNJ |
Johnson & Johnson
|
89,403 | $22,705,679 | |
| 3 | AMGN |
Amgen Inc
|
51,552 | $18,668,010 | |
| 4 | ABBV |
AbbVie Inc.
|
62,909 | $15,830,420 | |
| 5 | MRK |
Merck & Co., Inc.
|
79,617 | $10,230,784 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
66,482 | $8,399,335 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
115,747 | $6,669,342 | |
| 8 | NVS |
Novartis AG
|
39,351 | $6,167,088 |
All Filings in GRFS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $117,655 | 16,618 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $227,038 | 28,309 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||